CD177 and autoimmune disease: Despite limited studies that have primarily identified variations in CD177 expression and its correlation with diseases in the context of tumors, inflammation, and autoimmune disorders, there is a lack of in-depth mechanistic research and large-scale, multicenter prospective studies for validation.